Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zhonghua Yang, Shunping Li, Xuewen Wang & Gang Chen. (2022) Health state utility values derived from EQ-5D in psoriatic patients: a systematic review and meta-analysis. Journal of Dermatological Treatment 33:2, pages 1029-1036.
Read now
Read now
Articles from other publishers (17)
Naazish S. Bashir, Thomas D. Walters, Anne M. Griffiths, Anthony Otley, Jeff Critch & Wendy J. Ungar. (2023) A comparison of the Child Health Utility 9D and the Health Utilities Index for estimating health utilities in pediatric inflammatory bowel disease. Quality of Life Research 32:9, pages 2527-2539.
Crossref
Crossref
Damien S.E. Broekharst, Pepijn W.A. Thomas, Maurice G.V.M. Russel, Rachel L. West, Jeroen M. Jansen, Sjaak Bloem & Tessa E.H. Römkens. (2023) Health State Questionnaires Deployed in Ulcerative Colitis Patients: The Medical, Psychological, and Economic Perspective. Gastro Hep Advances 2:6, pages 770-777.
Crossref
Crossref
Sanja Vujovic, Jana Desnica, Dragana Stanisic, Irena Ognjanovic, Jovana Milenkovic, Momir Stevanovic, Gvozden Rosic, Nemanja Jovicic & Dragan Milovanovic. (2022) Systemic Diseases with Oral Manifestations and Their Impact on Health-Related Quality of Life. Experimental and Applied Biomedical Research (EABR) 0:0.
Crossref
Crossref
Raed A. Joundi, Joel Adekanye, Alexander A. Leung, Paul Ronksley, Eric E. Smith, Alexander D. Rebchuk, Thalia S. Field, Michael D. Hill, Stephen B. Wilton & Lauren C. Bresee. (2022) Health State Utility Values in People With Stroke: A Systematic Review and Meta‐Analysis. Journal of the American Heart Association 11:13.
Crossref
Crossref
SOUMYADIP GHOSH, DEBGOPAL GANGULY & SUBHABROTA MAJUMDER. (2022) A REVIEW ON PHARMACOLOGICAL AND THERAPEUTIC INSIGHT OF OZANIMOD FOR COLON DISEASE IN NANO-STRUCTURE. International Journal of Pharmacy and Pharmaceutical Sciences, pages 13-19.
Crossref
Crossref
Cyrus Alinia, Safura Yaghmaei, Farman Zahir Abdullah, Asad Ahmadi, Nasrin Samadi, Sima Pourteimour, Hossein Safari, Hassan Mahmoodi, Ghobad Moradi & Bakhtiar Piroozi. (2021) The health-related quality of life in Iranian patients with COVID-19. BMC Infectious Diseases 21:1.
Crossref
Crossref
Naazish S. Bashir, Thomas D. Walters, Anne M. Griffiths & Wendy J. Ungar. (2021) An Assessment of the Validity and Reliability of the Pediatric Child Health Utility 9D in Children with Inflammatory Bowel Disease. Children 8:5, pages 343.
Crossref
Crossref
Juan E Corral, Joshua Y Kwon, Freddy Caldera, Surakit Pungpapong, Aaron C Spaulding, Bijan J Borah, James P Moriarty & Francis A Farraye. (2021) Cost-Effectiveness of an Adjuvanted Hepatitis B Vaccine (HEPLISAV-B) in Patients With Inflammatory Bowel Disease. Crohn's & Colitis 360 3:1.
Crossref
Crossref
Ji-Hao Shi, Liang Luo, Xiao-Li Chen, Yi-Peng Pan, Zhou Zhang, Hao Fang, Ying Chen, Wen-Dong Chen & Qian Cao. (2020) Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn’s disease in China. World Journal of Gastroenterology 26:41, pages 6455-6474.
Crossref
Crossref
Vasileios Fragoulakis, Rossana Roncato, Chiara Dalle Fratte, Fabrizio Ecca, Marina Bartsakoulia, Federico Innocenti, Giuseppe Toffoli, Erika Cecchin, George P. Patrinos & Christina Mitropoulou. (2019) Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity. The American Journal of Human Genetics 104:6, pages 1158-1168.
Crossref
Crossref
Louise Longworth, Donna Fountain, Jeshika Singh, Ismail Azzabi, Glynn Owen, Ulf Lundstam & Shaji Sebastian. (2018) Elicitation of Health-Related Utility in Perianal Fistula in Crohn’s Disease. The Patient - Patient-Centered Outcomes Research 12:3, pages 339-348.
Crossref
Crossref
Fanni Rencz, Peep F. M. Stalmeier, Márta Péntek, Valentin Brodszky, Gábor Ruzsa, Lóránt Gönczi, Károly Palatka, László Herszényi, Eszter Schäfer, János Banai, Mariann Rutka, László Gulácsi & Peter L. Lakatos. (2019) Patient and general population values for luminal and perianal fistulising Crohn’s disease health states. The European Journal of Health Economics 20:S1, pages 91-100.
Crossref
Crossref
Feng Xie, Michael Zoratti, Kelvin Chan, Don Husereau, Murray Krahn, Oren Levine, Tammy Clifford, Holger Schunemann & Gordon Guyatt. (2019) Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB). Medical Decision Making 39:4, pages 371-379.
Crossref
Crossref
Fanni Rencz, Peter L. Lakatos, László Gulácsi, Valentin Brodszky, Zsuzsanna Kürti, Szilvia Lovas, János Banai, László Herszényi, Tamás Cserni, Tamás Molnár, Márta Péntek & Károly Palatka. (2018) Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease. Quality of Life Research 28:1, pages 141-152.
Crossref
Crossref
Stavros Petrou, Joseph Kwon & Jason Madan. (2018) A Practical Guide to Conducting a Systematic Review and Meta-analysis of Health State Utility Values. PharmacoEconomics 36:9, pages 1043-1061.
Crossref
Crossref
Joseph Kwon, Sung Wook Kim, Wendy J. Ungar, Kate Tsiplova, Jason Madan & Stavros Petrou. (2017) A Systematic Review and Meta-analysis of Childhood Health Utilities. Medical Decision Making 38:3, pages 277-305.
Crossref
Crossref
Przemysław Holko, Paweł Kawalec & Małgorzata Mossakowska. (2018) Quality of life related to oral, subcutaneous, and intravenous biologic treatment of inflammatory bowel disease: a time trade-off study. European Journal of Gastroenterology & Hepatology 30:2, pages 174-180.
Crossref
Crossref